200,000+ products from a single source!
sales@angenechem.com
232617-15-1 | 4-Thiazolidinecarboxylic acid, 2-[(1R,2R,3R)-1,2,3,4-tetrahydroxybutyl]-, (4R)-
CAS No: 232617-15-1 Catalog No: AG002MP8 MDL No:
Product Description
Catalog Number:
AG002MP8
Chemical Name:
4-Thiazolidinecarboxylic acid, 2-[(1R,2R,3R)-1,2,3,4-tetrahydroxybutyl]-, (4R)-
CAS Number:
232617-15-1
Molecular Formula:
C8H15NO6S
Molecular Weight:
253.2728
IUPAC Name:
(4R)-2-[(1R,2R,3R)-1,2,3,4-tetrahydroxybutyl]-1,3-thiazolidine-4-carboxylic acid
InChI:
InChI=1S/C8H15NO6S/c10-1-4(11)5(12)6(13)7-9-3(2-16-7)8(14)15/h3-7,9-13H,1-2H2,(H,14,15)/t3-,4+,5+,6+,7?/m0/s1
InChI Key:
AGZXTDUDXXPCMJ-HZYAIORGSA-N
SMILES:
OC[C@H]([C@H]([C@H](C1SC[C@H](N1)C(=O)O)O)O)O
UNII:
4PS0070ASU
Properties
Complexity:
253
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
4
Defined Bond Stereocenter Count:
0
Exact Mass:
253.062g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
8
Hydrogen Bond Donor Count:
6
Isotope Atom Count:
0
Molecular Weight:
253.269g/mol
Monoisotopic Mass:
253.062g/mol
Rotatable Bond Count:
5
Topological Polar Surface Area:
156A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
XLogP3:
-4.8
Literature
| Title | Journal |
|---|---|
| A maxed-out liver: a case of acute-on-chronic liver failure. | Seminars in liver disease 20111101 |
| Potential therapeutic advantage of ribose-cysteine in the inhibition of astrocytoma cell proliferation. | Amino acids 20110601 |
| Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model. | Translational research : the journal of laboratory and clinical medicine 20070801 |
| Effect of ribose cysteine pretreatment on hepatic and renal acetaminophen metabolite formation and glutathione depletion. | Basic & clinical pharmacology & toxicology 20050601 |
| A role for long-lived radicals (LLR) in radiation-induced mutation and persistent chromosomal instability: counteraction by ascorbate and RibCys but not DMSO. | Mutation research 20040713 |
| The 'pro-drug' RibCys decreases the mutagenicity of high-LET radiation in cultured mammalian cells. | Radiation research 20031101 |
| Ascorbate, added after irradiation, reduces the mutant yield and alters the spectrum of CD59- mutations in A(L) cells irradiated with high LET carbon ions. | Journal of radiation research 20021201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.